David A. Siegel Tenaya Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 51,800 shares of TNYA stock, worth $31,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,800Holding current value
$31,080% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$5.64 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$4.04 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$3.55 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$2.45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.44 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $24.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...